{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:55:27Z","timestamp":1781740527144,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47993-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:05:21Z","timestamp":1777025121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["XGBoost and SHAP based lymph node ratio thresholds for predicting overall survival in stage I to IIIA NSCLC"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuanyuan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shancheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"5","key":"47993_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/ejcts\/ezab375","volume":"60","author":"PE Falcoz","year":"2021","unstructured":"Falcoz, P. E. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database. Eur. J. Cardiothorac. Surg. 60 (5), 1221\u20131222 (2021).","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"11","key":"47993_CR2","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1097\/JTO.0000000000000334","volume":"9","author":"R Rami-Porta","year":"2014","unstructured":"Rami-Porta, R. et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J. Thorac. Oncol. 9 (11), 1618\u20131624 (2014).","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"47993_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","volume":"151","author":"FC Detterbeck","year":"2017","unstructured":"Detterbeck, F. C., Boffa, D. J., Kim, A. W. & Tanoue, L. T. The Eighth Edition Lung Cancer Stage Classification. Chest 151 (1), 193\u2013203 (2017).","journal-title":"Chest"},{"key":"47993_CR4","doi-asserted-by":"crossref","unstructured":"Nwogu, C. E. et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg. ;93(5):1614-9; discussion 9\u201320. (2012).","DOI":"10.1016\/j.athoracsur.2012.01.065"},{"issue":"9","key":"47993_CR5","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s10620-015-3681-1","volume":"60","author":"C Wei","year":"2015","unstructured":"Wei, C. et al. Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival. Dig. Dis. Sci. 60 (9), 2771\u20132776 (2015).","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"47993_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jamcollsurg.2007.09.003","volume":"206","author":"AJ Greenstein","year":"2008","unstructured":"Greenstein, A. J. et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. J. Am. Coll. Surg. 206 (2), 239\u2013246 (2008).","journal-title":"J. Am. Coll. Surg."},{"issue":"6","key":"47993_CR7","doi-asserted-by":"publisher","first-page":"R680","DOI":"10.1186\/bcr934","volume":"6","author":"V Vinh-Hung","year":"2004","unstructured":"Vinh-Hung, V. et al. Ratios of involved nodes in early breast cancer. Breast cancer research: BCR. 6 (6), R680\u2013R688 (2004).","journal-title":"Breast cancer research: BCR"},{"issue":"3","key":"47993_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/01.ju.0000032474.22093.06","volume":"169","author":"HW Herr","year":"2003","unstructured":"Herr, H. W. Superiority of ratio based lymph node staging for bladder cancer. J. Urol. 169 (3), 943\u2013945 (2003).","journal-title":"J. Urol."},{"key":"47993_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.oraloncology.2018.01.021","volume":"78","author":"HI Kim","year":"2018","unstructured":"Kim, H. I. et al. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis. Oral Oncol. 78, 80\u201386 (2018).","journal-title":"Oral Oncol."},{"issue":"9","key":"47993_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1245\/ASO.2003.03.520","volume":"10","author":"D Nitti","year":"2003","unstructured":"Nitti, D. et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann. Surg. Oncol. 10 (9), 1077\u20131085 (2003).","journal-title":"Ann. Surg. Oncol."},{"issue":"9","key":"47993_CR11","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1245\/s10434-016-5243-y","volume":"23","author":"N Amini","year":"2016","unstructured":"Amini, N. et al. Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study. Ann. Surg. Oncol. 23 (9), 3016\u20133023 (2016).","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"47993_CR12","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1245\/s10434-006-9322-3","volume":"14","author":"HY Lee","year":"2007","unstructured":"Lee, H. Y. et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann. Surg. Oncol. 14 (5), 1712\u20131717 (2007).","journal-title":"Ann. Surg. Oncol."},{"issue":"34","key":"47993_CR13","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.1200\/JCO.2005.02.8852","volume":"23","author":"AC Berger","year":"2005","unstructured":"Berger, A. C. et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J. Clin. oncology: official J. Am. Soc. Clin. Oncol. 23 (34), 8706\u20138712 (2005).","journal-title":"J. Clin. oncology: official J. Am. Soc. Clin. Oncol."},{"issue":"7","key":"47993_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1001\/jamadermatol.2019.0267","volume":"155","author":"S Cheraghlou","year":"2019","unstructured":"Cheraghlou, S., Agogo, G. O. & Girardi, M. Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma. JAMA dermatology. 155 (7), 803\u2013811 (2019).","journal-title":"JAMA dermatology"},{"issue":"3","key":"47993_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1245\/s10434-008-0265-8","volume":"16","author":"R Vather","year":"2009","unstructured":"Vather, R., Sammour, T., Kahokehr, A., Connolly, A. B. & Hill, A. G. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study. Ann. Surg. Oncol. 16 (3), 585\u2013593 (2009).","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"47993_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ejcts\/ezab287","volume":"60","author":"H Yang","year":"2021","unstructured":"Yang, H. & Mei, T. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database. Eur. J. Cardiothorac. Surg. 60 (5), 1212\u20131220 (2021).","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"1","key":"47993_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw, P. et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J. Thorac. Oncol. 11 (1), 39\u201351 (2016).","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"47993_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","volume":"49","author":"R Rami-Porta","year":"2005","unstructured":"Rami-Porta, R., Wittekind, C. & Goldstraw, P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 49 (1), 25\u201333 (2005).","journal-title":"Lung Cancer"},{"issue":"1","key":"47993_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41598-017-00619-5","volume":"7","author":"N Ding","year":"2017","unstructured":"Ding, N. et al. Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC. Sci. Rep. 7 (1), 584 (2017).","journal-title":"Sci. Rep."},{"issue":"9","key":"47993_CR20","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jtho.2016.05.004","volume":"11","author":"X Ding","year":"2016","unstructured":"Ding, X. et al. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer. J. Thorac. Oncol. 11 (9), 1565\u20131573 (2016).","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"47993_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ijrobp.2008.08.065","volume":"74","author":"YS Kim","year":"2009","unstructured":"Kim, Y. S. et al. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 74 (3), 796\u2013802 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"47993_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/thx.2010.148601","volume":"66","author":"JP Wisnivesky","year":"2011","unstructured":"Wisnivesky, J. P., Arciniega, J., Mhango, G., Mandeli, J. & Halm, E. A. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax 66 (4), 287\u2013293 (2011).","journal-title":"Thorax"},{"issue":"1","key":"47993_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12957-016-1048-5","volume":"14","author":"M Tamura","year":"2016","unstructured":"Tamura, M. et al. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer. World J. Surg. Oncol. 14 (1), 295 (2016).","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"47993_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ejcts\/ezy311","volume":"55","author":"M Chiappetta","year":"2019","unstructured":"Chiappetta, M. et al. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis\u2020. Eur. J. Cardiothorac. Surg. 55 (3), 405\u2013412 (2019).","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"47993_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.lungcan.2009.02.024","volume":"66","author":"E Bria","year":"2009","unstructured":"Bria, E. et al. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer. 66 (3), 365\u2013371 (2009).","journal-title":"Lung Cancer"},{"issue":"1","key":"47993_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.athoracsur.2004.06.081","volume":"79","author":"M Riquet","year":"2005","unstructured":"Riquet, M. et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann. Thorac. Surg. 79 (1), 225\u2013233 (2005).","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"47993_CR27","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.chest.2021.05.014","volume":"160","author":"F Li","year":"2021","unstructured":"Li, F. et al. Comparison of Two Proposed Changes to the Current Nodal Classification for Non\u2013small Cell Lung Cancer Based on the Number and Ratio of Metastatic Lymph Nodes. Chest 160 (4), 1520\u20131533 (2021).","journal-title":"Chest"},{"issue":"7","key":"47993_CR28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/JTO.0b013e318292c53e","volume":"8","author":"D Urban","year":"2013","unstructured":"Urban, D., Bar, J., Solomon, B. & Ball, D. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer. J. Thorac. Oncol. 8 (7), 940\u2013946 (2013).","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"47993_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00408-019-00284-7","volume":"197","author":"WQ Zeng","year":"2019","unstructured":"Zeng, W. Q. et al. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study. Lung 197 (6), 741\u2013751 (2019).","journal-title":"Lung"},{"issue":"1","key":"47993_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jjco\/hyz120","volume":"50","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis. Jpn J. Clin. Oncol. 50 (1), 44\u201357 (2020).","journal-title":"Jpn J. Clin. Oncol."},{"issue":"1","key":"47993_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12672-022-00542-w","volume":"13","author":"N Feng","year":"2022","unstructured":"Feng, N. et al. Lymph node ratio predicts overall survival in patients with stage II non-small cell lung cancer: a population-based SEER analysis. Discover Oncol. 13 (1), 75 (2022).","journal-title":"Discover Oncol."},{"issue":"2","key":"47993_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.athoracsur.2013.03.102","volume":"96","author":"TW Rice","year":"2013","unstructured":"Rice, T. W. & Blackstone, E. H. Lymph node ratio: a confounded quotient. Ann. Thorac. Surg. 96 (2), 744 (2013).","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"47993_CR33","first-page":"602","volume":"244","author":"SL Chen","year":"2006","unstructured":"Chen, S. L. & Bilchik, A. J. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann. Surg. 244 (4), 602\u2013610 (2006).","journal-title":"Ann. Surg."},{"issue":"9","key":"47993_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/bjs.5349","volume":"93","author":"S Manfredi","year":"2006","unstructured":"Manfredi, S. et al. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br. J. Surg. 93 (9), 1115\u20131122 (2006).","journal-title":"Br. J. Surg."},{"issue":"45","key":"47993_CR35","doi-asserted-by":"publisher","first-page":"79387","DOI":"10.18632\/oncotarget.18154","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer. Oncotarget 8 (45), 79387\u201379396 (2017).","journal-title":"Oncotarget"},{"issue":"4","key":"47993_CR36","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1378\/chest.13-0073","volume":"144","author":"ZM Li","year":"2013","unstructured":"Li, Z. M. et al. Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancer. Chest 144 (4), 1253\u20131260 (2013).","journal-title":"Chest"},{"issue":"1","key":"47993_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.suronc.2017.01.004","volume":"26","author":"D Dziedzic","year":"2017","unstructured":"Dziedzic, D., Piotr, R., Langfort, R. & Orlowski, T. Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. Surg. Oncol. 26 (1), 80\u201385 (2017).","journal-title":"Surg. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47993-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:35:26Z","timestamp":1781739326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47993-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47993"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47993-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Review and approval by an ethics committee was not needed for this study because difficulties in identifying patients in SEER database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"18947"}}